Portugal, June 17 -- Portugal based AMGEN BIOFARMACEUTICA, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - ENZALUTAMIDA [40 MG; CAP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS]. The value of the contract is worth 18816000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....